Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Regulatory B cells contribute to the impaired antitumor immunity in ovarian cancer patients.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 May 2016

Wei Xin, Jin Yangqiu, Tian Yinpu, Zhang Huiyuan, Wu Jie, Lu Wei, Lu Xiaofen

Abstract excerpt

Multiple factors in the tumor microenvironment were found to inhibit antitumor adaptive immune responses, allowing tumor persistence and growth. In this study, ascites from ovarian cancer patients were collected. We observed that a population of interleukin-10(+) B (IL-10(+) B) cells was preferentially enriched in the ascites. This population was associated with naive B cell phenotype or IgM or class-switched...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immunity
Share to Immunologic Memory

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immunophenotyping

Share to Lymphocyte Count

Share to Lymphocytes, Tumor-Infiltrating

Share to Neoplasm Grading

Share to Ovarian Neoplasms

Share to T-Lymphocyte Subsets

Source

Identifiers

PMID: 26638169
DOI: 10.1007/s13277-015-4538-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Regulatory B cells contribute to the impaired antitumor immunity in ovarian cancer patients.PMID 26638169Read ↗

Revealing the role of regulatory b cells in cancer: development, function and treatment significanceSemantic proximity Read ↗

B10 cells: Development, phenotype, and function in cancer.Semantic proximity Read ↗

Positive and negative functions of B lymphocytes in tumorsSemantic proximity Read ↗

Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment.Semantic proximity Read ↗

Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma.Semantic proximity Read ↗

The Ratios of CD8+ T Cells to CD4+CD25+ FOXP3+ and FOXP3- T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian CancerSemantic proximity Read ↗

The Emerging Role of B Cells in Tumor ImmunitySemantic proximity Read ↗

CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer.Semantic proximity Read ↗

Study of immunomics and immune regulation in ovarian cancerSemantic proximity Read ↗

Frequency of regulatory B cells phenotypes in breast cancer patients in Egypt.Semantic proximity Read ↗

A new perspective: Exploring future therapeutic strategies for cancer by understanding the dual role of B lymphocytes in tumor immunitySemantic proximity Read ↗

Immunotherapy with IL-10- and IFN-γ-producing CD4 effector cells modulate "Natural" and "Inducible" CD4 TReg cell subpopulation levels: observations in four cases of patients with ovarian cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.